Clinical Trial Update: A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)

View source ↗

Summary

This document covers a planned retrospective real-world study assessing the efficacy and safety of using Anlotinib hydrochloride in combination with immunothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer Extensive Stage

Drugs mentioned

• Anlotinib hydrochloride (anlotinib)
• Immunotherapy maintenance therapy

Snippet

Sponsor: Yong Fang | Conditions: Small Cell Lung Cancer Extensive Stage | Status: NOT_YET_RECRUITING